About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Inflammation in the MPNs: Updates and Future Directions from ASH 2017
By
Angela Fleischman
6 Videos
137 views
March 5, 2018
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
08:44
American Contact Dermatitis Society (ACDS)
What to Do When Patch Testing is Negative?
Feat.
M. Montanez-Wiscovich
21:52
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…
Feat.
D. Tremblay
10:02
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…
Feat.
R. Mesa
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
11:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates in Myeloproliferative Neoplasms
Feat.
E. Hexner
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Chronic GVHD: A Case-Based Discussion
Feat.
L. Perry
27:47
City of Hope
Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…
Feat.
I. Amanam
22:30
Indy Hematology Review
Targets and Treatments of MPNs in 2023
Feat.
R. Mesa
23:12
Total Health
West Oncology Conference: Overview and Updates in MPNs
Feat.
J. Chandler
09:08
Paul Kaesberg
Itching in PV (and Other MPNs)
08:24
ASH 2022 Conference Coverage
Phase 2 FIGHT-203 Study: Pemigatinib in Pts With Myeloid/Lymphoid Ne…
Feat.
A. Vannucchi
17:49
Yale Cancer Center
Yale ASH Highlights - Myeloid Malignancies: Focus on MPNs
Feat.
N. Podoltsev
32:39
MyCancerHaven
Experts Discuss the Basics of Allogeneic Stem Cell Transplant
Feat.
R. Vij,
M. Christopher
16:48
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Choosing and Properly Using a JAK Inhibitor in Myelofibro…
Feat.
A. Hunter
20:06
UChicago Medicine
Updates in MPNs
Feat.
A. Patel
06:46
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Guadecitabine in Higher-Risk MDS and CMML U…
Feat.
S. Urrutia
17:23
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient
New Approaches to Preventing and Treating GVHD
Feat.
N. Hossain
15:35
SOHO Turkey 2023
SOHO Turkey 2023: WHO Classification of MPNs - Transitioning From th…
Feat.
H. Hamed
10:51
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: Myeloproliferative Neoplasms
Feat.
J. Mascarenhas